Physician profile
Le Tchen
NPI 1043504814
$1,107.16
in general payments reported to CMS, 2019-2025
14 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $100 · 2022: $198 · 2023: $245 · 2024: $180 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $599.55 | 2021-2025 | Collagenase Santyl, Regranex, Renasys Touch |
| Organogenesis INC. | $100.13 | 2021-2025 | Cygnus Dual, Affinity |
| Paratek Pharmaceuticals, INC. | $93.96 | 2022-2025 | Nuzyra |
| Kci USA, INC. | $50.00 | 2022 | |
| Solventum Corporation | $45.93 | 2025 | Activ.A.C. |
| Cashflow Solutions, LLC | $36.09 | 2024-2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Abbvie INC. | $30.36 | 2025 | |
| Tactile Systems Technology INC | $27.36 | 2023 | Flexitouch Plus, Entre Plus |
| Convatec INC. | $26.93 | 2021 | |
| Acera Surgical, INC. | $25.26 | 2022 | |
| Melinta Therapeutics, LLC | $23.62 | 2023 | Orbactiv, Kimyrsa |
| Fidia Pharma USA INC. | $16.87 | 2025 | |
| Stryker Corporation | $16.13 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Hartmann USA, INC. | $14.97 | 2025 | Zetuvit Plus 10x10 P10 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Le Tchen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.